Beyond its glucose-dependent enhancement of insulin secretion, GLP-1 was shown to suppress inappropriate glucagon release, slow gastric emptying, promote satiety through central appetite pathways, and favor weight reduction—properties that aligned seamlessly with clinical goals for diabetes and obesity management. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.